Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03164798 : Serum BDNF Role as a Biomarker for Stroke Rehabilitation
AgesMin: 19 Years Max: N/A
Inclusion Criteria:

- unilateral stroke patients

- admission to the rehabilitation department before 1 month after stroke onset

- mild to severe motor impairment at time of transferring to the rehabilitation

Exclusion Criteria:

- Progressive or unstable stroke

- Pre-existing and active major neurological disease

- Pre-existing and active major psychiatric disease

- Advanced liver, kidney, cardiac, or pulmonary disease

- A terminal medical diagnosis consistent with survival < 1 year)

- Pregnant or lactating woman
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557